International Conference on Oncolytic Virus Therapeutics aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Oncolytic Viruses and Immunotherapy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Oncolytic Viruses and Immunotherapy. Oncolytic Virus is an international platform for presenting research about Virus Outbreaks, control and Therapy. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. Oncolytic viruses are a novel class of anti-cancer agents which in many cases have entered clinical trials. These viruses are capable of attacking cancer cells in a distinctive manner leading to cell-specific and targeted tumor therapy.